Tectonic Therapeutic, Inc.
Clinical-stage biotech developing biologics targeting G-Protein Coupled Receptors (GPCRs).
TECX | US
Overview
Corporate Details
- ISIN(s):
- US05455M1009
- LEI:
- Country:
- United States of America
- Address:
- 490 ARSENAL WAY, 2472 WATERTOWN
- Website:
- https://tectonictx.com/
Description
Tectonic Therapeutic, Inc. is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs). The company utilizes its proprietary GEODe™ technology platform to design and create biologic medicines targeting this complex class of receptors. Tectonic's approach aims to address significant unmet medical needs in diseases where therapeutic options are limited or nonexistent. Its pipeline includes differentiated GPCR-targeted biologics for conditions such as Group 2 Pulmonary Hypertension and Hereditary Hemorrhagic Telangiectasia (HHT).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Tectonic Therapeutic, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Tectonic Therapeutic, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Tectonic Therapeutic, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
